Category: Steris Corp.
Steris expands its specialty services business with the $165 million acquisition of Integrated Medical Systems and its surgical instrument repair, management and processing services.
Steris (NYSE:STE) announced this week plans to acquire Integrated Medical Systems in a deal worth up to $175 million. Steris will pay $165 million to acquire the instrument services company, plus another $10 million for real estate, according to a press release.
Steris Corp. said it plans to shutter a plant in Ohio and lay off about 150 workers, or nearly 3% of its workforce.
Steris (NYSE:STE) said it plans to close down a plant in its Mentor, Ohio, base and lay off about 150 workers worldwide.
The layoffs represent a 2.5% cut to the workforce at Steris, which employed about 6,000 workers as of March 31, 2013, according to a regulatory filing.
Zynex CEO Thomas Sandgaard downsizes the company's board of directors as part of a larger strategy to restructure the company.
Zynex (OTC:ZYXI) CEO Thomas Sandgaard has cleared the path to reshape the company after cutting its board in half.
Sandgaard asked for the resignations of board members Mats Wahlstrom, Mary Beth Vitale, Kevin Smith and Taylor Simonton, to add board members who share Sandgaard's vision for the rehab devices maker.
A more than $9 million tax charge related to the restructuring of its European operations pushes fiscal 1st-quarter earnings down for Steris Corp.
Steris posts a mixed bag in Q1, strong sales and earnings offset by restructuring costs and per-share earnings that miss expectations by 1 cent.
Steris (NYSE:STE) took a hit during its fiscal 1st quarter from a $9.2 million tax charge over its restructuring in Europe, but posted a more than 9% top-line gain.
Steris beats the Street with strong figures for its 4th-quarter and full year of 2013.
Steris (NYSE:STE) stocks surged after posting Q4 figures that beat Wall Street expectations. The company reported per-share earnings of 70¢, which is 5¢ better than analysts' consensus estimate, sending shares up 3.5 points by market close on May 7.
Steris Corp. boosts its year-end outlook as profits jump 43% during its fiscal 3rd quarter.
Steris (NYSE:STE) boosted its bottom line by 43% during its fiscal 3rd quarter, increasing its year-end guidance in the process.
Shares of Hologic hit a 52-week high yesterday on a study showing the benefits of mammography using its Selenia 3D device.
Hologic (NSDQ:HOLX) shares hit a 52-week high yesterday on news that mammography using 3D technology significantly improved diagnostic accuracy.
HOLX shares reached their highest level since May 2011 yesterday, peaking at $23.22 apiece before closing at $22.36, up 7.0% on the day. Shares were trading at $22.39 as of about 12:50 p.m. today.